Skip to main content
. 2022 Jun 22;81:104109. doi: 10.1016/j.ebiom.2022.104109

Figure 2.

Figure 2

Setup and basic principle of FEASI. a, Schematic overview of the anti-IgG (left) and the FcγR-IgG ELISA (right); b, Recombinant anti-spike monoclonal antibody COVA1-1840 glycoengineered to contain high and low levels of fucose probed with the anti-IgG, and c, the FcγR-IgG ELISA. Error bars represent standard deviation of three measurements.